An Open, Two-period, Fixed-sequence, Phase I Trial to Evaluate the Effect of Multiple Doses of BI 1356 on the Multiple-dose Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel
Latest Information Update: 03 Jul 2014
At a glance
- Drugs Linagliptin (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Diabetic nephropathies; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
Most Recent Events
- 03 Jul 2014 New trial record